enVVeno Medical Corporation
At Close: 4:00 PM
NVNO Stock Price Graph
NVNO Stock Price Today
enVVeno Medical Corporation (NVNO) stock declined over -3.28% intraday to trade at $3.83 a share on NASDAQ. The stock opened with a gain of 39.47% at $5.30 and touched an intraday high of $5.30, rising 0.79% against the last close of $3.80. The enVVeno Medical Corporation in stock market went to a low of $5.10 during the session.
NVNO Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
NVNO Stock Price History Chart
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Frequently Asked Questions
What is the current enVVeno Medical Corporation (NVNO) stock price?
enVVeno Medical Corporation (NASDAQ: NVNO) stock price is $3.83 in the last trading session. During the trading session, NVNO stock reached the peak price of $5.30 while $5.10 was the lowest point it dropped to. The percentage change in NVNO stock occurred in the recent session was -3.28% while the dollar amount for the price change in NVNO stock was -$0.13.
NVNO's industry and sector of operation?
The NASDAQ listed NVNO is part of Medical Devices industry that operates in the broader Healthcare sector. enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency.
Who are the executives of NVNO?
Mr. Craig Thomas Glynn
Chief Financial Officer, Treasurer & Sec.
Mr. Robert A. Berman
Chief Executive Officer & Director
Dr. Marc H. Glickman M.D.
Senior Vice President & Chief Medical Officer
Dr. Hamed Alavi Ph.D.
Senior Vice President & Chief Technology Officer
How NVNO did perform over past 52-week?
NVNO's closing price is 0.12% higher than its 52-week low of $2.51 where as its distance from 52-week high of $6.49 is -0.53%.
How many employees does NVNO have?
Number of NVNO employees currently stands at N/A. NVNO operates from 70 Doppler, Irvine, CA 92618, US.
Link for NVNO official website?
Official Website of NVNO is: https://www.envveno.com
How do I contact NVNO?
How many shares of NVNO are traded daily?
NVNO stock volume for the day was 126248.00 shares. The average number of NVNO shares traded daily for last 3 months was 61.24 Thousands.
What is the market cap of NVNO currently?
The market value of NVNO currently stands at $51.02 Million with its latest stock price at $3.83 and N/A of its shares outstanding.